Skip to main content
Back to Sequoia Capital

Sequoia Capital's Biotechnology Portfolio

Browse 2 Biotechnology companies funded by Sequoia Capital. See funding amounts, founder contacts, and investment details.

Biotechnology Companies
2
Total Funding in Biotechnology
$35.0M

Biotechnology Portfolio Companies (2)

Export
BiotechnologyHealth CareMedicalPharmaceuticalTherapeutics

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

South San Francisco, United States
May 2026
Post-IPO Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareMedicalTherapeutics

Vivace Therapeutics is a venture-backed start-up dedicated to discovering and developing cancer therapeutics by targeting a novel pathway.

San Mateo, United States
March 2025
$35.0M
Series D

Founder Contacts

19,000+ verified contacts

Explore Sequoia Capital's Full Portfolio

View all companies funded by Sequoia Capital across every industry and funding stage.

View Full Sequoia Capital Portfolio